Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-03-18 17:23 Tx date 2024-02-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-15,000 vol |
33,000 | |
Filed 2023-11-15 15:10 Tx date 2023-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+24,000 vol |
131,000 | |
Filed 2023-10-24 13:21 Tx date 2023-07-31 |
$SALT
Atlas Salt Inc. |
LaBelle, Richard Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights PSU
00 - Opening Balance-Initial SEDI Report
|
1,400,000 | ||
Filed 2023-10-24 13:19 Tx date 2023-07-31 |
$SALT
Atlas Salt Inc. |
LaBelle, Richard Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
Filed 2023-06-30 16:50 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,790 vol |
19,847 | |
Filed 2023-06-30 16:49 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-3,210 vol |
18,000 | |
Filed 2023-06-30 16:49 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,790 vol |
21,210 | |
Filed 2023-06-26 19:49 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-3,210 vol |
||
Filed 2023-06-26 19:49 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,790 vol |
||
Filed 2023-06-26 19:49 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,790 vol |
||
Filed 2023-06-26 18:29 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,790 vol |
19,847 | |
Filed 2023-06-26 18:29 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,790 vol |
||
Filed 2023-06-26 18:29 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-3,210 vol |
18,000 | |
Filed 2023-06-26 18:29 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-3,210 vol |
||
Filed 2023-06-26 18:28 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,790 vol |
||
Filed 2023-06-26 18:28 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,790 vol |
21,210 | |
Filed 2022-11-30 11:59 Tx date 2022-11-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,000 vol |
24,000 | |
Filed 2022-11-30 11:59 Tx date 2014-02-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-22 15:00 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,472
+3,260 vol $7.20 each |
17,057 | |
Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
||
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+107,000 vol |
107,000 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-672,000 vol |
48,000 | |
Filed 2018-12-21 Tx date 2014-02-17 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-193,162 vol |
13,797 | |
Filed 2017-09-06 Tx date 2017-09-01 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+60,000 vol $0.25 each |
206,959 | |
Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
720,000 | |
Filed 2016-08-18 Tx date 2016-08-18 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$15,750
+52,500 vol $0.30 each |
146,959 | |
Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,370
+31,000 vol $0.27 each |
92,559 | |
Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+10,000 vol $0.265 each |
61,559 | |
Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,820
+7,000 vol $0.26 each |
51,559 | |
Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,550
+10,000 vol $0.255 each |
44,559 | |
Filed 2016-07-28 Tx date 2016-07-28 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$522.50
+1,900 vol $0.275 each |
94,459 | |
Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
620,000 | |
Filed 2015-08-26 Tx date 2015-08-25 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$11,750
+34,559 vol $0.34 each |
34,559 | |
Filed 2015-08-26 Tx date 2014-02-17 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,300
+145,000 vol $0.34 each |
370,000 |